InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: jadite post# 7166

Tuesday, 11/21/2017 8:24:55 PM

Tuesday, November 21, 2017 8:24:55 PM

Post# of 14871
Jadite, Smile, by the look of AbbVie's recent latest patent application, it looks like they still support topical & transdermal method of delivery.

BACKGROUND OF THE INVENTION

[0002] Compared to other delivery methods and systems, transdermal or topical drug delivery systems present great advantages, including non-invasiveness, higher concentrations at the site of action, prolonged therapeutic effect, reduced systemic side effects, better patient compliance and easy termination of drug therapy.



Topical Formulation

It goes on to include testosterone among other drugs in its uses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News